HealthcareLife and DeathPhysicianUncategorized

Surgeons Reflect on a Year of Living and Working with COVID-19

By May 12, 2021No Comments

What we learned and what we still don’t know. What went well, and what work remains to be done.

Exponential vs. linear growth

The virus spreads by exponential growth. Humans have a hard time recognizing the power of exponential growth. For the most part, we live in a linear world. If you get paid two hundred dollars a week, then on week one you have $200, on week two $400 and so on so that in ten weeks you have $2000. But if something grows exponentially, it doubles on a regular interval. At first, it looks like linear growth as 200 infected people become 400, but after that, 400 becomes 800, and it continues to double. After ten weeks, you have more than 200,000 people infected. 2,000 versus 200,000 is the impact of exponential growth.

The problem with any response to a pandemic

The problem with the response to a pandemic is that you can never get it right. If you respond forcefully and the action taken is effective, then the pandemic never proves as bad as expected, and your actions look like an overreaction. On the other hand, take a passive approach to the problem, and large numbers of people get sick and die. No matter what action world leaders take, they will look like it was the wrong action one way or the other.

It demonstrated major flaws in the healthcare system.

The American healthcare system was strained to deal with the emergency. Medical systems built on profit first had moved to staff for efficiency and on-demand supply chains. With no warehousing of medical supplies, personal protective equipment (PPE), medications, and equipment like ventilators, the system could not address the crisis. In my hospital, masks were rationed and even “recycled,” so single-use masks could be reissued to the next employee. Glove supplies ran out, and health providers had to share protective gowns.

It’s not getting better.

The failure of the health systems to address the problem and change their business model is dangerous because of variants of the virus. The more people who get infected, the more opportunities the virus has to mutate and change. That could mean more infective and destructive mutations. There is no guarantee that today’s vaccine will protect people against possible variation in the future. With over 148 million people infected worldwide, that is a lot of opportunities for mutations to occur. We can’t afford to assume the worst of this is behind us and go back to business as usual. The world has never had COVID-19 before (No, it is not the 19th COVID strain we have seen, the 19 comes from the year it was isolated), and we can’t predict what might happen. There is just too much we don’t know.

What we still don’t know

We can‘t know how long the virus will last. Coronavirus may be a need reality we need to learn how to live with it. Or it may be like prior pandemics, such as the Spanish flu or SARS, that ran their courses and then stopped being a problem. Only time will tell. But we can’t afford to engage in wishful thinking and assume it will magically go away. The prudent solution is to prepare ourselves and our health care systems, like Coronavirus is here to stay. As we say in surgery, “Hope for the best but prepare for the worst.”

Long-COVID

One area of concern that is still not getting the attention it deserves is the long-term sequela of COVID-19 infection. Known as Long COVID, this constellates symptoms that people continue to experience months after “recovering” from COIVD infection. Rather than the exception, Long COVID may be the norm. A Lancet study found that 76% of patients continued to experience at least one symptom six months after becoming ill.

  • Shortness of breath or difficulty breathing
  • Cough
  • Joint pain
  • Chest pain
  • Memory, concentration, or sleep problems
  • Muscle pain or headache
  • Fast or pounding heartbeat
  • Loss of smell or taste
  • Depression or anxiety
  • Fever
  • Dizziness when you stand
  • Worsened symptoms after physical or mental activities

What went well

Will these worst-case scenarios prove true? There is no way to know. But it is not all bad news. The pharmaceutical companies have been able to turn out safe and effective vaccines for COIVD-19 in less than a year. That is an astounding accomplishment due to a Herculean effort on the manufacturers and novel vaccine production approaches. And the role out in vaccinations in the United States has been very successful so far, with nearly 40% of Americans receiving at least one dose of the vaccine and a quarter of Americans fully vaccinated.

Work is still not done.

However, this a global problem, and other countries have not seen the success the USA has. Much of Africa and Asia have vaccinated less than 1% of their population because they lack access to the vaccine. While this might not sound like a problem for us in the USA, but it is. The more people in the world that become infected, the more opportunities the virus has to mutate. The mutations can be more infective, more malignant, and resistant to the current vaccine. And remember, COVID first occurred in China but rapidly spread to the rest of the world. A new variant could do the same thing no matter where it forms.

What needs to happen

We have had some success with our response to this pandemic. But we have a long way to go. Health systems need to be more robust, but that will not happen while they are more profitable when they are fragile. Despite the cost, hospitals need to stockpile equipment and supplies in preparation for the next crisis — and there will be the next crisis. Healthcare systems also need to maintain staffing so the hospital can function at full capacity, even if that means overstaffing during times of decreased demand. After all, we don’t pay firefighters only when there is a fire and leave them unemployed the rest of the time. Why would we do that with essential healthcare workers?

 

Get Started Today! Sign up for my newsletter and stay updated.